A. Blazevic

发表

Mycobacterium-Specific γ9δ2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity

C. Spencer, M. Xia, G. Abate, 2015, Infection and Immunity.

Dipterinyl Calcium Pentahydrate Inhibits Intracellular Mycobacterial Growth in Human Monocytes via the C-C Chemokine MIP-1β and Nitric Oxide

R. Silver, D. Hoft, Phillip B. B. Moheno, 2013, Infection and Immunity.

Polyclonal Mucosa-Associated Invariant T Cells Have Unique Innate Functions in Bacterial Infection

D. Hoft, S. Truscott, C. Eickhoff, 2012, Infection and Immunity.

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

D. Zak, Garnet Navarro, A. Aderem, 2016, EBioMedicine.

The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Travis L. Jensen, Johannes B. Goll, M. Mulligan, 2022, bioRxiv.

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.

B. Landry, J. McClain, J. Sadoff, 2012, Vaccine.

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults

R. Belshe, K. Lottenbach, D. Hoft, 2016, Clinical and Vaccine Immunology.

Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites

D. Fremont, J. McCluskey, J. Rossjohn, 2015, The Journal of Immunology.

Specific for Riboflavin Metabolites Mucosal-Associated Invariant T Cells Antimycobacterial Effects of Mouse Functional Heterogeneity and

D. Fremont, J. McCluskey, J. Rossjohn, 2015 .

Only a Subset of Phosphoantigen-Responsive γ9δ2 T Cells Mediate Protective Tuberculosis Immunity1

C. Spencer, G. Abate, D. Hoft, 2008, The Journal of Immunology.

Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity.

C. Spencer, G. Abate, D. Hoft, 2008, Journal of immunology.

Induction of mycobacterial protective immunity by sublingual BCG vaccination.

D. Hoft, C. Eickhoff, A. Blazevic, 2019, Vaccine.

Pilot studies of a human BCG challenge model.

M. Xia, D. Hoft, A. Blazevic, 2017, Tuberculosis.

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Alison E Kosel, K. Meyer, M. Robb, 2017, The Lancet.

Mycobacterium-Speciﬁc (cid:2) 9 (cid:3) 2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity

C. Spencer, M. Xia, G. Abate, 2016 .

Investigations of TB vaccine-induced mucosal protection in mice.

D. Hoft, Jill M. Schriewer, C. Eickhoff, 2014, Microbes and infection.

Enhancement of Innate and Cell-Mediated Immunity by Antimycobacterial Antibodies

G. Abate, D. Hoft, R. Heuertz, 2005, Infection and Immunity.

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

Kousuke Saito, M. Ait-goughoulte, K. Meyer, 2008, Journal of Virology.

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production (cid:1)

Kousuke Saito, M. Ait-goughoulte, K. Meyer, 2008 .

Immunity T Cells Mediate Protective Tuberculosis 2 δ 9 γa Subset of Phosphoantigen-Responsive

C. Spencer, G. Abate, D. Hoft, 2013 .

Only a Subset of Phosphoantigen-responsive γ 9 δ 2 T cells Mediate Protective TB Immunity 1

C. Spencer, G. Abate, D. Hoft, 2009 .

Granzyme A Produced by γ9δ2 T Cells Induces Human Macrophages to Inhibit Growth of an Intracellular Pathogen

C. Spencer, M. Xia, Guangyong Peng, 2013, PLoS pathogens.

Co-Administration of a Plasmid DNA Encoding IL-15 Improves Long-Term Protection of a Genetic Vaccine against Trypanosoma cruzi

M. Rodrigues, D. Hoft, J. R. Vasconcelos, 2011, PLoS neglected tropical diseases.

PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4+ T cell transcriptomal molecular signatures

V. Brusic, P. Andersen, G. Matuschak, 2017, Mucosal Immunology.

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.

G. Kaplan, W. Hanekom, M. Horwitz, 2008, The Journal of infectious diseases.

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

Lisa Ondrejcek, C. Fox, C. Casper, 2023, Nature Communications.

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

D. Zak, Garnet Navarro, A. Aderem, 2016, EBioMedicine.

A Subset of Mycobacteria-Specific CD4+ IFN-γ+ T Cell Expressing Naive Phenotype Confers Protection against Tuberculosis Infection in the Lung

Jinyun Yuan, D. Hoft, Soumya Chatterjee, 2019, The Journal of Immunology.

Mycobacteria-specific CD4+IFN-γ+ cell expresses naïve-surface markers and confers superior protection against tuberculosis infection compared to central and effector memory CD4+ T cell subsets

Jinyun Yuan, D. Hoft, Soumya Chatterjee, 2018, bioRxiv.

Impact of BCG vaccination on the repertoire of human γδ T cell receptors

A. Fiore-Gartland, D. Hoft, A. Blazevic, 2023, Frontiers in Immunology.